ArticlePain and therapy2026

Long-Term Reductions in Headache Frequency, Severity, and Disability with Eptinezumab in Adults with Chronic Migraine: Results from the PREVAIL Trial.

Amaal J Starling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.